Acadia Pharmaceuticals Executives Sell Shares Amid Market Volatility

Acadia Pharmaceuticals Inc. (ACAD) has disclosed that Kihara James, Principal Accounting Officer, sold 833 shares at $21.47 on March 25, 2026, and 1097 shares at $21.65 on March 26, 2026, in addition to 12 shares at $21.73 on the same day. Furthermore, Owen Adams Catherine, Director and Chief Executive Officer, sold 11,641 shares at $21.47 on March 25, 2026, while EVP, Chief Legal Officer, SEC Rhodes Jennifer J sold 3,844 shares at the same price on March 25, 2026. EVP, Chief Financial Officer Schneyer Mark C. sold 4,177 shares at $21.47 on March 25, 2026, and an additional 3,171 shares at $21.65 on March 26, 2026, as well as 37 shares at $21.72 on the same day. Lastly, EVP, Head of Research & Development Thompson Elizabeth H.Z. sold 3,435 shares at $21.47 on March 25, 2026.